Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
genentech
4
×
life sciences
national blog main
4
×
national top stories
san francisco top stories
boston blog main
boston top stories
clinical trials
eli lilly
fda
roche
san francisco blog main
avapritinib
blueprint medicines
boston
cancer
deals
europe top stories
indiana blog main
indiana top stories
investing
medullary thyroid cancer
national
new york top stories
non-small cell lung cancer
novartis
pralsetinib
selpercatinib
thyroid cancer
4d molecular therapeutics
abbvie
acne
agenus
astrazeneca
auris health
avexis
bayer
billy dunn
biogen
What
drug
4
×
fda
4
×
approval
approved
blueprint
cancer
medicines
ret
roche
therapy
address
approves
atrophy
bio
candidate
carries
certain
companies
currently
daily
designed
digital
disease
epidemic
evrysdi
fatty
frenzied
friday
genetic
green
growing
home
intended
known
latest
led
lights
liquid
liver
marketing
Language
unset
Current search:
genentech
×
biotech
×
drug
×
" national blog main "
×
fda
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More